HCA INC/TN (HCA) has 449 open-market insider trades by 72 insiders since 2006. The most active filer is Michael S. Cuffe, VP.
| Name | Title | Tier | Trades | Value | Last Trade |
|---|---|---|---|---|---|
| Holding Ii Llc Hercules | 10% | — | 5 | $7.8B | 2016-09-23 |
| Stephen G. Pagliuca | Dir | — | 5 | $3.2B | 2014-12-05 |
| Christopher R. Gordon | Dir | — | 4 | $2.5B | 2013-11-01 |
| John Connaughton | Dir | — | 4 | $2.5B | 2013-11-01 |
| Henry R. Kravis | 10% Owner | — | 3 | $2.1B | 2016-05-10 |
| KKR 2006 GP LLC | 10% Owner | — | 2 | $1.7B | 2016-05-10 |
| KKR Group Ltd | 10% | — | 2 | $1.5B | 2013-11-01 |
| Bain Capital Integral Investors 2006, LLC | 10% | — | 2 | $1.3B | 2013-02-15 |
| Associates 8 Na L.p. Kkr | 10% | — | 2 | $1.3B | 2013-02-15 |
| KKR Partners III, L.P. | 10% | — | 2 | $961.1M | 2012-12-14 |
| Insider | Title | Type | Value | Date |
|---|---|---|---|---|
| Michael R. McAlevey | CLO & VP | Sell | $904K | 2026-02-18 |
| Christopher F. Wyatt | Controller | Sell | $2.0M | 2026-02-11 |
| Jennifer Berres | VP | Sell | $4.1M | 2026-02-11 |
| Michael S. Cuffe | EVP and Chief Clinical Officer | Sell | $747K | 2026-02-03 |
| Samuel N. Hazen | CEO | Sell | $21.5M | 2026-02-03 |
| Michael R. McAlevey | CLO & VP | Sell | $3.7M |
Companies that share insiders with HCA, and sector peers with recent insider buying. Related by who files, not by how the stocks move.
| 2025-11-05 |
| Michael S. Cuffe | VP | Sell | $3.2M | 2025-09-08 |
| Jon M. Foster | COO & VP | Sell | $11.6M | 2025-05-13 |
| Jennifer Berres | VP | Sell | $6.2M | 2025-02-14 |
| Phillip G. Billington | VP | Sell | $1.4M | 2024-11-14 |
| Erol R. Akdamar | President | Sell | $1.0M | 2024-11-14 |
| Kathleen M. Whalen | VP | Sell | $1.1M | 2024-11-14 |
| Michael S. Cuffe | VP | Sell | $6.4M | 2024-09-12 |
| Deborah M. Reiner | VP | Sell | $2.4M | 2024-07-29 |
| Kathleen M. Whalen | VP | Sell | $3.5M | 2024-07-29 |